Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

v3.19.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2019
Revenue Recognition [Abstract]  
Schedule of revenue recognition

Revenue by Service Line

 

    Three Months Ended March 31,  
    2019     2018  
Products:            
Disposable products:                
Functional neurosurgery   $ 1,604,645     $ 1,161,335  
Biologics and drug delivery     284,910       198,465  
Capital equipment     274,399       178,798  
Total product revenue     2,163,953       1,538,598  
Services:                
Capital equipment and other     211,202       84,768  
Biologics and drug delivery     97,362       -  
Total service revenue     308,564       84,768  
Total revenue   $ 2,472,517     $ 1,623,366